BR0102289A - Diazepinoindóis para o tratamento de doença pulmonar obstrutiva crÈnica - Google Patents

Diazepinoindóis para o tratamento de doença pulmonar obstrutiva crÈnica

Info

Publication number
BR0102289A
BR0102289A BR0102289-0A BR0102289A BR0102289A BR 0102289 A BR0102289 A BR 0102289A BR 0102289 A BR0102289 A BR 0102289A BR 0102289 A BR0102289 A BR 0102289A
Authority
BR
Brazil
Prior art keywords
treatment
pulmonary disease
chronic obstructive
obstructive pulmonary
diazepinoindoles
Prior art date
Application number
BR0102289-0A
Other languages
English (en)
Inventor
Annette Doherty
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0102289A publication Critical patent/BR0102289A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Patente de Invenção: "DIAZEPINOINDóIS PARA O TRATAMENTO DE DOENçA PULMONAR OBSTRUTIVA CRÈNICA". A presente invenção refere-se ao uso de diazepinoindol da fórmula (I): em que A é arila ou heteroarila contendo nitrogênio e B é um ou radical hidroxila amino, para o tratamento de doença pulmonária obstrutiva crónica.
BR0102289-0A 2000-06-09 2001-06-07 Diazepinoindóis para o tratamento de doença pulmonar obstrutiva crÈnica BR0102289A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00401646A EP1161949A1 (en) 2000-06-09 2000-06-09 Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease

Publications (1)

Publication Number Publication Date
BR0102289A true BR0102289A (pt) 2002-03-12

Family

ID=8173724

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0102289-0A BR0102289A (pt) 2000-06-09 2001-06-07 Diazepinoindóis para o tratamento de doença pulmonar obstrutiva crÈnica

Country Status (19)

Country Link
US (1) US6544983B2 (pt)
EP (1) EP1161949A1 (pt)
JP (1) JP2002138090A (pt)
KR (1) KR20010111457A (pt)
CN (1) CN1345725A (pt)
AR (1) AR030291A1 (pt)
AU (1) AU5181301A (pt)
BR (1) BR0102289A (pt)
CA (1) CA2347337A1 (pt)
CZ (1) CZ20011999A3 (pt)
EA (1) EA200100515A3 (pt)
HU (1) HUP0102388A3 (pt)
IL (1) IL143636A0 (pt)
MX (1) MXPA01005726A (pt)
NO (1) NO20012831L (pt)
NZ (1) NZ512222A (pt)
PL (1) PL347922A1 (pt)
SK (1) SK7832001A3 (pt)
ZA (1) ZA200104616B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20090274676A1 (en) * 2003-07-31 2009-11-05 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050085430A1 (en) * 2003-07-31 2005-04-21 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
PL1685849T3 (pl) 2003-11-20 2012-07-31 Astellas Pharma Inc Inhibitory PDE 4 do leczenia śródmiąższowego zapalenia pęcherza moczowego
DE102004002557A1 (de) * 2004-01-17 2005-08-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen
KR20150081370A (ko) 2006-07-10 2015-07-13 파이온 유케이 리미티드 속효형 벤조디아제핀 염 및 이의 중합체 형태
CA2711865A1 (en) 2008-01-11 2009-07-16 Astellas Pharma Inc. A pathological animal model simultaneously developing testicular pain or discomfort behaviors and urinary frequency
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
MA37581B1 (fr) * 2012-05-22 2016-07-29 Paion Uk Ltd Compositions comprenant des benzodiazépines à action rapide
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2652352A1 (fr) 1989-09-28 1991-03-29 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique.
FR2725719B1 (fr) 1994-10-14 1996-12-06 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases iv
FR2746800B1 (fr) * 1996-03-29 1998-06-05 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases 4
FR2762841B1 (fr) 1997-04-30 1999-07-02 Jouveinal Inst Rech Diazepino-indolones inhibitrices de phosphodiesterases iv

Also Published As

Publication number Publication date
CA2347337A1 (en) 2001-12-09
HUP0102388A2 (hu) 2002-04-29
NO20012831L (no) 2001-12-10
SK7832001A3 (en) 2002-05-09
CZ20011999A3 (cs) 2002-04-17
EA200100515A2 (ru) 2001-12-24
EP1161949A1 (en) 2001-12-12
HU0102388D0 (en) 2001-08-28
KR20010111457A (ko) 2001-12-19
HUP0102388A3 (en) 2004-11-29
EA200100515A3 (ru) 2002-06-27
AU5181301A (en) 2001-12-13
NO20012831D0 (no) 2001-06-08
AR030291A1 (es) 2003-08-20
US6544983B2 (en) 2003-04-08
NZ512222A (en) 2002-10-25
PL347922A1 (en) 2001-12-17
IL143636A0 (en) 2002-04-21
ZA200104616B (en) 2002-10-30
JP2002138090A (ja) 2002-05-14
MXPA01005726A (es) 2003-08-20
US20020010175A1 (en) 2002-01-24
CN1345725A (zh) 2002-04-24

Similar Documents

Publication Publication Date Title
NL300877I2 (nl) obeticholzuur
BRPI0410170A (pt) preparação e uso de derivados de ácido aril alquìlico para o tratamento de obesidade
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
BR9806752A (pt) Ftalazinonas.
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
ES2248356T3 (es) Compuestos para tratar la enfermedad de alzheimer.
BR0012888A (pt) Inibidores derivados de purina de proteìna tirosina sic quinase
AR087241A2 (es) Derivados de 6-oh-4h-benzo[1,4]oxazin-3-ona para el tratamiento de la enfermedad pulmonar obstructiva cronica
EA200601591A1 (ru) Применение рибонуклеозидных соединений для лечения флавивирусных и пестивирусных инфекций
BR0115411A (pt) Combinações sinergìsticas compreendendo um inibidor de renina para doenças cardiovasculares
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
BR0102289A (pt) Diazepinoindóis para o tratamento de doença pulmonar obstrutiva crÈnica
BR0113590A (pt) 7-oxo-piridopirimidinas
WO2002002520A8 (en) Compounds to treat alzheimer's disease
BR0316169A (pt) Derivados de indolil pirazinona úteis para tratamento de distúrbios e doenças hiperproliferativos associados com angiogênese
BR9911666A (pt) Combinação farmacêutica, uso da combinação, processo para tratamento de uma doença inflamatória em uma pessoa sofrendo de ou susceptìvel a tal doença, e, composição farmacêutica
BR0309095A (pt) Uso de osteoprotegerina para o tratamento e/ou prevenção de doença fibrótica
ATE385419T1 (de) Dermatologische und kosmetische zusammensetzungen enthaltend ein furfurylderivat
BRPI0510084A (pt) benzoxazina para tratamento de doenças do trato respiratório
BR0010604A (pt) Uso de phyllanthus para o tratamento de processos inflamatórios e fibróticos crÈnicos
BR0113389A (pt) Compostos que inibem a atividade do fator xa
BR0110210A (pt) Compostos para o tratamento de fibromialgia e sìndrome de fadiga crÈnica
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
BR0213037A (pt) Derivados de pirimidina
RS8504A (en) Novel cyclohexil sulphones

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008.